Target
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Ligand
BDBM347425
Substrate
n/a
Meas. Tech.
In Vitro Assay
IC50
4.01±n/a nM
Citation
 Markowitz, SWillson, JKPosner, BReady, JAntczak, MZhang, YDesai, AGerson, SGreenlee, W Compositions and methods of modulating short-chain dehydrogenase activity US Patent  US9789116 Publication Date 10/17/2017 
Target
Name:
15-hydroxyprostaglandin dehydrogenase [NAD(+)]
Synonyms:
15-PGDH | 15-hydroxyprostaglandin dehydrogenase [NAD+] | HPGD | PGDH1 | PGDH_HUMAN | Prostaglandin dehydrogenase 1 (15-PGDH) | SDR36C1
Type:
Enzyme
Mol. Mass.:
28974.46
Organism:
Homo sapiens (Human)
Description:
P15428
Residue:
266
Sequence:
MHVNGKVALVTGAAQGIGRAFAEALLLKGAKVALVDWNLEAGVQCKAALDEQFEPQKTLFIQCDVADQQQLRDTFRKVVDHFGRLDILVNNAGVNNEKNWEKTLQINLVSVISGTYLGLDYMSKQNGGEGGIIINMSSLAGLMPVAQQPVYCASKHGIVGFTRSAALAANLMNSGVRLNAICPGFVNTAILESIEKEENMGQYIEYKDHIKDMIKYYGILDPPLIANGLITLIEDDALNGAIMKITTSKGIHFQDYDTTPFQAKTQ
  
Inhibitor
Name:
BDBM347425
Synonyms:
US10869871, ID # SW209330 | US20230285402, ID # SW209330 | US9789116, SW209330
Type:
Small organic molecule
Emp. Form.:
C20H17ClN2OS3
Mol. Mass.:
433.01
SMILES:
Nc1c(sc2nc(cc(-c3ccccc3)c12)-c1cccs1)[S+]([O-])CCCCl
Structure:
Search PDB for entries with ligand similarity: